Abstract
The HIV-1 Nef protein is an accessory protein of 24-27 kDa mass that mediates a multitude of effector functions in infected cells. Although not essentially required for viral replication, HIV-1 Nef exhibits stimulating potential towards disease progression to AIDS and is therefore considered a pathogenic factor in retroviridae. Here we correlate sequence conservation in HIV-1 Nef with surface hydrophobicity and functionality in protein-protein interaction to identify accessible substructures on the surface of Nef that might be suitable as pharmacological target sites. Recent advances in targeting of Nef by small molecular compounds that interfere with SH3 domain binding or MHC class I down-regulation are discussed. Similarly, approaches for the use of larger molecules are introduced, such as tailored fusion proteins that simultaneously interact with multiple highly conserved sequence motifs of Nef. In addition, the design of a single domain antibody from llama that interferes with CD4 down-regulation activity and PAK2 binding is discussed. The flexibility in binding recognition is exemplarily shown for the modulation of RT-loop binding using engineered SH3 domains. The various considerations corroborate the potential of HIV-1 Nef as a promising target for the development of potent Nef inhibitors.
Keywords: HIV-1, Nef, protein-protein interaction, SH3, small molecule inhibitors, CD3, PHARMACEUTICAL TARGET, PPIs, Hot spots, DFP-4AP
Current HIV Research
Title: Nef Surfaces: Where to Interfere with Function
Volume: 9 Issue: 7
Author(s): Sebastian Lulf, Florian A. Horenkamp, Sebastian Breuer and Matthias Geyer
Affiliation:
Keywords: HIV-1, Nef, protein-protein interaction, SH3, small molecule inhibitors, CD3, PHARMACEUTICAL TARGET, PPIs, Hot spots, DFP-4AP
Abstract: The HIV-1 Nef protein is an accessory protein of 24-27 kDa mass that mediates a multitude of effector functions in infected cells. Although not essentially required for viral replication, HIV-1 Nef exhibits stimulating potential towards disease progression to AIDS and is therefore considered a pathogenic factor in retroviridae. Here we correlate sequence conservation in HIV-1 Nef with surface hydrophobicity and functionality in protein-protein interaction to identify accessible substructures on the surface of Nef that might be suitable as pharmacological target sites. Recent advances in targeting of Nef by small molecular compounds that interfere with SH3 domain binding or MHC class I down-regulation are discussed. Similarly, approaches for the use of larger molecules are introduced, such as tailored fusion proteins that simultaneously interact with multiple highly conserved sequence motifs of Nef. In addition, the design of a single domain antibody from llama that interferes with CD4 down-regulation activity and PAK2 binding is discussed. The flexibility in binding recognition is exemplarily shown for the modulation of RT-loop binding using engineered SH3 domains. The various considerations corroborate the potential of HIV-1 Nef as a promising target for the development of potent Nef inhibitors.
Export Options
About this article
Cite this article as:
Lulf Sebastian, A. Horenkamp Florian, Breuer Sebastian and Geyer Matthias, Nef Surfaces: Where to Interfere with Function, Current HIV Research 2011; 9 (7) . https://dx.doi.org/10.2174/157016211798842053
DOI https://dx.doi.org/10.2174/157016211798842053 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Multi-dimensional Review on Severe Acute Respiratory Syndrome
Coronavirus-2
Current Pharmaceutical Biotechnology Synthesis of N-Substituted Benzamide Derivatives and their Evaluation as Antitumor Agents
Medicinal Chemistry Tyrosinase Inhibitory Activity of S-Naproxen Derivatives
Letters in Drug Design & Discovery Ghrelin Receptor Ligands: Design and Synthesis of Pseudopeptides and Peptidomimetics
Current Chemical Biology Design, Synthesis, and Delivery Studies of Organotin(IV) based HCV Inhibitor
Infectious Disorders - Drug Targets Renal Solute Transporters and Their Relevance to Serum Urate Disorder
Current Hypertension Reviews Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Eating Disorders in the Time of the COVID-19 Pandemic: A Perspective
Endocrine, Metabolic & Immune Disorders - Drug Targets Small Molecule Inhibitors of the p53-MDM2
Current Medicinal Chemistry 3D-QSAR Study on a Series of Bcl-2 Protein Inhibitors Using Comparative Molecular Field Analysis
Protein & Peptide Letters Depressive Illness and Emotional Learning
Current Medical Imaging Clinical Approaches to Minimize Readmissions of Patients with COPD: A Narrative Review
Current Respiratory Medicine Reviews Neuroinflammation, Microglia and Mast Cells in the Pathophysiology of Neurocognitive Disorders: A Review
CNS & Neurological Disorders - Drug Targets Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Therapeutic Potential of Targeting Hsp90-Cdc37 Interactions in Several Diseases
Current Drug Targets Dengue, Influenza and COVID-19 in Brazil: The “Perfect Storm”
Coronaviruses Algae Polysaccharides’ Chemical Characterization and their Role in the Inflammatory Process
Current Medicinal Chemistry Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands
Mini-Reviews in Medicinal Chemistry Hybrid Bioactive Heterocycles as Potential Antimicrobial Agents: A Review
Mini-Reviews in Medicinal Chemistry Preface
Recent Patents on Engineering